Q-omics provides the consensus-scored RPS26P43 profile across patient tissues and cancer cell-line models. RPS26P43 expression is associated with patient survival in 11 of 34 cancer types, with the highest sampling consensus in BLCA. Additionally, RPS26P43 RNA expression shows 5,672 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight BLCA, and STAD as cancer lineages where RPS26P43 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for RPS26P43 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes RPS26P43 survival associations across molecular data types. RPS26P43 RNA expression shows survival associations in the most cancer types (11). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

RPS26P43 data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	11	BLCA (63)	view →

This table ranks reproducible RPS26P43 RNA expression–survival associations across cancer types. High RPS26P43 expression shows unfavorable associations in BLCA, ACC, LUAD, CHOL and STAD, but favorable associations in OV. The BLCA Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .015). Together, the overview and detailed table identify BLCA as the clearest survival context for RPS26P43 RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	III,IV	0.367	0.495	.015	63	view →
ACC	OS	Tertile	II,III,IV	0.308	0.798	.003	25	view →
LUAD	OS	Tertile	III,IV	0.312	0.601	.003	24	view →
CHOL	DFS	Tertile	All	0.101	0.468	.028	24	view →
OV	OS	Quartile	IV	0.854	0.560	.007	16	view →
STAD	OS	Median	II,III,IV	0.622	0.783	.037	9	view →

Pink = unfavorable, green = favorable. all 11 lineages →

RPS26P43-BLCA (DFS)

Kaplan–Meier survival curve for RPS26P43 RNA expression in BLCA: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with RPS26P43 in patient tissues and cancer cell lines. In patient samples, RPS26P43 shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Function (RNA)	5,672	STAD (4479)	view →
Protein (mass-spec)	4,078	CCRCC (1057)	view →